Antimüllerian hormone as a serum marker of granulosa cell tumors of the ovary: Comparative study with serum α-inhibin and estradiol


      OBJECTIVE: Our purpose was to evaluate serum antimüllerian hormone as a marker for granulosa cell tumors. STUDY DESIGN: Serum antimüllerian hormone concentrations were determined in 16 patients with an adult-type granulosa cell tumor; in female patients with ovarian adenocarcinoma, benign ovarian cysts, or extraovarian cancers; and in normal premenopausal and postmenopausal women. Serum antimüllerian hormone, α-inhibin, and estradiol levels were compared in 10 patients with a granulosa cell tumor during 6 to 47 months of follow-up. RESULTS: Serum antimüllerian hormone was undetectable in normal postmenopausal women and was <5 μg/L in premenopausal women. Normal serum levels were found in patients with ovarian cancers or cysts or with extraovarian cancers. Levels were between 6.8 and 117.9 μg/L in eight of nine patients with a progressive granulosa cell tumor. In the remaining case antimüllerian hormone, α-inhibin and estradiol concentrations were normal. Serum antimüllerian hormone and α-inhibin levels became elevated at least 11 months before the recurrence was clinically detectable. During clinical remission serum antimüllerian hormone, α-inhibin, and estradiol were normal in most cases. CONCLUSION: Serum antimüllerian hormone is a sensitive, specific, reliable marker of adult-type granulosa cell tumors and is useful to evaluate the efficacy of treatment and to detect recurrences early. (AM J OBSTET GYNECOL 1996;174:958-65.)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Young RH
        • Scully RE
        Endocrine tumors of the ovary.
        in: Current topics in pathology. 85. : Springer-Verlag, Berlin1992: 114-164
        • Fox H
        Sex cord-stromal tumors of the ovary.
        J Pathol. 1985; 145: 127-148
        • Schwartz PE
        • Smith JP
        Treatment of ovarian stromal tumors.
        AM J OBSTET GYNECOL. 1976; 125: 402-411
        • Stenwig JT
        • Hazenkamp JT
        • Beecham JB
        Granulosa cell tumors of the ovary: a clinicopathological study of 118 cases with long-term follow-up.
        Gynecol Oncol. 1979; 7: 136-152
        • Evans III, AT
        • Gafey TA
        • Malkasian GDJ
        • Annegers JF
        Clinicopathological review of 118 granulosa and 82 theca cell tumors.
        Obstet Gynecol. 1980; 55: 231-238
        • Kauppila A
        • Bangah M
        • Burger H
        • Martikainen H
        GnRH agonist analog therapy in advanced/recurrent granulosa cell tumors: further evidence of a role of inhibin in monitoring response to treatment.
        Gynaecol Endocrinol. 1992; 6: 271-274
        • Josso N
        • Cate RL
        • Picard JY
        • et al.
        Anti-müllerian hormone, the Jost factor.
        in: Recent progress in hormone research. 48. : Academic Press, San Diego1993: 1-59
        • Ueno S
        • Takahashi M
        • Manganaro TF
        • Ragin RC
        • Donahoe PK
        Cellular localization of müllerian inhibiting substance in the developing rat ovary.
        Endocrinology. 1989; 124: 1000-1006
        • Bézard J
        • Vigier B
        • Tran D
        • Mauléon P
        • Josso N
        Immunocytochemical study of anti-müllerian hormone in sheep ovarian follicles during fetal and postnatal development.
        J Reprod Fertil. 1987; 80: 509-516
        • Vigier B
        • Picard JY
        • Tran D
        • Legeai L
        • Josso N
        Production of anti-müllerian hormone: another homology between Sertoli and granulosa cells.
        Endocrinology. 1984; 114: 1315-1320
        • Takahashi M
        • Hayashi M
        • Manganaro TF
        • Donahoe PK
        The ontogeny of müllerian inhibiting substance in granulosa cells of the bovine ovarian follicle.
        Biol Reprod. 1986; 35: 447-454
        • Picard JY
        • Benarous R
        • Guerrier D
        • Josso N
        • Kahn A
        Cloning and expression of cDNA for anti-müllerian hormone.
        Proc Natl Acad Sci U S A. 1986; 83: 5464-5468
        • Hudson PL
        • Dougas I
        • Donahoe PK
        • et al.
        An immunoassay to detect human müllerian inhibiting substance in males and females during normal development.
        J Clin Endocrinol Metab. 1990; 70: 16-22
        • Gustafson ML
        • Lee MM
        • Scully RE
        • et al.
        Müllerian inhibiting substance as a marker for ovarian sex-cord tumor.
        N Engl J Med. 1992; 326: 466-471
        • Kaye SB
        • Davies E
        Cyclophosphamide, adriamycin and cis-platinum for treatment of advanced granulosa cell tumors, using serum estradiol as a tumor marker.
        Gynecol Oncol. 1986; 24: 261-264
        • Burger HG
        Inhibin as a tumour marker.
        Clin Endocrinol. 1994; 41: 151-153
        • Carré-Eusèbe D
        • Imbeaud S
        • Harbison M
        • New MI
        • Josso N
        • Picard JY
        Variants of the anti-müllerian hormone gene in a compound heterozygote with the persistent müllerian duct syndrome and his family.
        Hum Genet. 1992; 90: 389-394
        • Lahlou N
        • Le Nestour E
        • Chanson P
        • et al.
        Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumor volume in men.
        Clin Endocrinol. 1993; 38: 301-309
        • Robertson DM
        • Tsonis CG
        • McLachlan RI
        • et al.
        Comparison of inhibin immunological and in vitro biological activities in human serum.
        J Clin Endocrinol Metab. 1988; 67: 438-443
        • Josso N
        • Lamarre I
        • Picard JY
        • et al.
        Anti-müllerian hormone in early human development.
        Early Hum Dev. 1993; 33: 91-99
        • Rodgers KE
        • Marks JF
        • Ellefson DD
        • et al.
        Follicle regulatory protein: a novel marker for granulosa cell cancer patients.
        Gynecol Oncol. 1990; 37: 381-387
        • Lappöhn RE
        • Burger HG
        • Bouma J
        • Bangah M
        • Krans M
        • de Bruijn HWA
        Inhibin as a marker for granulosa-cell tumors.
        N Engl J Med. 1989; 321: 790-793
        • Jobling T
        • Mamers P
        • Healy DL
        • et al.
        A prospective study of inhibin in granulosa cell tumors of the ovary.
        Gynecol Oncol. 1994; 55: 285-289
        • Healy DL
        • Burger HG
        • Mamers P
        • et al.
        Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
        N Engl J Med. 1993; 329: 1539-1542